SynthesisExpert review of pharmacoeconomics & outcomes research2016
The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review.
Synthesis in Expert review of pharmacoeconomics & outcomes research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review of healthcare costs related to mental health conditions among cancer survivors.Expert review of pharmacoeconomics & outcomes research · 2018Pooled it
- Health care cost trajectories among patients with cancer and cardiometabolic comorbidities over a decade including the pandemic period.Journal of managed care & specialty pharmacy · 2026Article
- Long-term costs associated with healthcare use of people with cancer in Scotland.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Comorbidity prevalence and incidence in cancer survivors: a longitudinal All of Us study.JNCI cancer spectrum · 2025Article
- General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.Journal of patient-reported outcomes · 2024Article
- Importance of Patient Health Insurance Coverage and Out-of-Pocket Costs for Genomic Testing in Oncologists' Treatment Decisions.JCO oncology practice · 2024Article
- Predictive and Interpretable Machine Learning of Economic Burden: The Role of Chronic Conditions Among Elderly Patients with Incident Primary Merkel Cell Carcinoma (MCC).ClinicoEconomics and outcomes research : CEOR · 2024Article
- Impact of functional disability on health-care use and medical costs among cancer survivors.JNCI cancer spectrum · 2023Article
- Article
- The prevalence and correlates of comorbidities among patients with cancer attending a tertiary care cancer center in South India: An analytical cross-sectional study.Cancer research, statistics, and treatment · 2023Article
- Cancer Survivors' Long-Term Health Service Costs in Queensland, Australia: Results of a Population-Level Data Linkage Study (Cos-Q).International journal of environmental research and public health · 2022Article
- Research on the Economics of Cancer-Related Health Care: An Overview of the Review Literature.Journal of the National Cancer Institute. Monographs · 2022Review
- Association of co-morbidities with financial hardship in survivors of adult cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Healthcare utilization and spending among older patients diagnosed with Non-Hodgkin lymphoma.Journal of geriatric oncology · 2021Article
- Psychological Distress and Access to Mental Health Services Among Cancer Survivors: a National Health Interview Survey Analysis.Journal of general internal medicine · 2021Article
- The financial coping strategies of US cancer patients and survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.Head & neck · 2021Article
- Geriatric conditions and treatment burden following diagnosis of non-muscle- invasive bladder cancer in older adults: A population-based analysis.Journal of geriatric oncology · 2021Article
- Arterial stiffness is associated with cardiovascular and cancer mortality in cancer patients: Insight from NHANESIII.International Journal of Cardiology. Hypertension · 2021Article
- Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionThis systematic review examines the excess cost of chronic conditions on the economic burden of cancer survivorship among adults in the US. Areas covered: Twelve published studies were identified. Although studies varied substantially in populations, comorbidities examined, methods, and types of cost reported, costs for cancer survivors with comorbidities generally increased with greater numbers of comorbidities or an increase in comorbidity index score. Survivors with comorbidities incurred significantly more in total medical costs, out-of-pocket costs, and costs by service type compared to cancer survivors without additional comorbidities. Expert commentary: Cancer survivors with comorbidities bear significant excess out-of-pocket costs and their care is also more expensive to the healthcare system. On-going evaluation of different payment models, care coordination, and disease management programs for cancer survivors with comorbidities will be important in monitoring impact on healthcare costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.